Amarantus Bioscience Holdings Inc (AMBS)

[Goldstrike]

Great article, thanks for posting: "RBCC is already hard at work helping to bring incredible new healthcare technologies to new markets. The company's joint venture partner, Nano3D BioSciences (n3D) has developed a revolutionary 3D cell-culturing system that could soon lead to a breakthrough in cancer research. RBCC has also finalized joint venture terms with Amarantus BioSciences (AMBS), makers of a ground-breaking new blood-test diagnostic for Parkinson's disease."
The NIBA conference is being held November 14-16 at the Venetian is Las Vegas. That's today through Friday of this week. Looks like RBCC is on the fast track!